Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
Clinical trial NCT04622345 · COMPLETED
Trial details
- NCT number
- NCT04622345
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-21
- Primary completion
- 2021-05-22
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.